Meccellis Biotech Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$8.25M
- Investors
-
5
Meccellis Biotech General Information
Description
Developer of biological implants designed for tissue repair. The company specializes in tissue and cell engineering and offers biological systems for the repair of soft tissues, such as abdominal wall repair and more, during surgery, enabling surgeons and patients to identify unmet clinical needs and offer an adapted solution by type of surgery.
Contact Information
Website
www.meccellis.comCorporate Office
- 75 rue de Québec
- 17000 La Rochelle
- France
Corporate Office
- 75 rue de Québec
- 17000 La Rochelle
- France
Meccellis Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 29-Nov-2022 | $8.25M | Completed | Generating Revenue | ||
| 2. Later Stage VC | 01-Sep-2018 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 06-Jul-2015 | $279K | $279K | Completed | Generating Revenue |
Meccellis Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Meccellis Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Meccellis Biotech Patents
Meccellis Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3082725-A1 | Acellular dermal matrix, especially for breast prosthesis | Inactive | 22-Jun-2018 | ||
| EP-3810034-A1 | Acellular dermal matrix, in particular for a mammary prosthesis | Active | 22-Jun-2018 | ||
| EP-3810034-B1 | Acellular dermal matrix, in particular for a mammary prosthesis | Active | 22-Jun-2018 | ||
| US-20210260245-A1 | Acellular dermal matrix, in particular for a mammary prosthesis | Inactive | 22-Jun-2018 | ||
| WO-2019243599-A1 | Acellular dermal matrix, in particular for a mammary prosthesis | Inactive | 22-Jun-2018 | A61F2/12 |
Meccellis Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Meccellis Biotech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nouvelle Aquitaine Co-Investissement | Venture Capital | Minority | ||
| Synergence | Angel Group | Minority | ||
| Volney Development SAS | Corporation | Minority | ||
| Ocean Participations | PE/Buyout | Minority | ||
| Aquiti | PE/Buyout | Minority |
Meccellis Biotech FAQs
-
When was Meccellis Biotech founded?
Meccellis Biotech was founded in 2011.
-
Where is Meccellis Biotech headquartered?
Meccellis Biotech is headquartered in La Rochelle, France.
-
What is the size of Meccellis Biotech?
Meccellis Biotech has 10 total employees.
-
What industry is Meccellis Biotech in?
Meccellis Biotech’s primary industry is Therapeutic Devices.
-
Is Meccellis Biotech a private or public company?
Meccellis Biotech is a Private company.
-
What is Meccellis Biotech’s current revenue?
The current revenue for Meccellis Biotech is .
-
How much funding has Meccellis Biotech raised over time?
Meccellis Biotech has raised $9.5M.
-
Who are Meccellis Biotech’s investors?
Nouvelle Aquitaine Co-Investissement, Synergence, Volney Development SAS, Ocean Participations, and Aquiti have invested in Meccellis Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
